Delivery Order SPE2DB22D3401-SPE2DB25FT4NM
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,456.77 and provides for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication, through April 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which enables Amerisourcebergen to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,203.97. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,747,323 units of the drug Budesonide-Formoterol 160-4.5 10.2GM, with a ceiling value of $1,696.32 and a period of performance through December 18, 2024. This contract is not designated as a set-aside and is a firm-fixed-price delivery order under a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,455.63, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,062,481 units of the medication Budesonide-Formoterol 160-4.5 10.2GM. The contract is a firm fixed-price delivery order with a ceiling value of $1,747.20 and a period of performance through April 29, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,522.36. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, and has a total ceiling value of $16,773.40. The contract is a firm fixed-price delivery order with a performance period ending on February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 80-4.5 10.2GM. The delivery order has a firm fixed price of $1,078.45 and a completion date of June 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,772,504 units of budesonide-formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The delivery order is valued at $2,620.80 and has a firm fixed price pricing type. The contract has an ultimate completion date of April 3, 2025 and was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,373.88 and a period of performance through April 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen...